Rationale for IL-15 superagonists in cancer immunotherapy - Wikidata - awgldk - TriplyDB

Rationale for IL-15 superagonists in cancer immunotherapy

Rationale for IL-15 superagonists in cancer immunotherapy

http://www.wikidata.org/entity/Q90227161

about

Rationale for IL-15 superagonists in cancer immunotherapy

http://www.wikidata.org/entity/Q90227161

description

scientific article published on 11 March 2020

@en

name

Rationale for IL-15 superagonists in cancer immunotherapy

@en

type

label

Rationale for IL-15 superagonists in cancer immunotherapy

@en

prefLabel

Rationale for IL-15 superagonists in cancer immunotherapy

@en

P1433

Q90227161-EC2D7405-BF35-40B5-B224-E6EB662946A4

P1476

Q90227161-F37EB4C2-E8D5-4320-8345-A603E3B0B237

P2093

Q90227161-1A1F44A0-DF78-4C45-9E97-79DAB31E9BB0

Q90227161-A5463BE5-B021-4DFD-A080-0D718FB53659

P304

Q90227161-2561260A-D93C-4A19-BC12-A08062095728

P31

Q90227161-358FC41D-B3AB-4DFF-92C2-C490111BFE15

Q90227161-f31a4b0d-bab4-41a2-85a5-d3494bb21b79

P356

Q90227161-144A1453-EC3C-4DAF-9EBF-76EB93A09F37

P50

Q90227161-B91CC733-AB27-4759-BDC9-BD412651F263

Q90227161-CB13B4F8-6250-48E9-9E53-BC561FF87745

P577

Q90227161-9ACD7833-7190-45AE-92DF-6447DF5AA231

P698

Q90227161-E54183CE-ECFB-4DBE-BC98-DDAFEF1BE2C6

P356

14712598.2020.1738379

P1433

Expert Opinion on Biological Therapy

P1476

Rationale for IL-15 superagonists in cancer immunotherapy

@en

P2093

James W Hodge

http://www.w3.org/2001/XMLSchema#string

Karin M Knudson

http://www.w3.org/2001/XMLSchema#string

P304

1-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14712598.2020.1738379

http://www.w3.org/2001/XMLSchema#string

P50

Sofia R Gameiro

P577

2020-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

32159390

http://www.w3.org/2001/XMLSchema#string